Acapatamab clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2019
How each study uses acapatamab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2021 (2)
| Year | Studies |
|---|---|
| 2019 | 1 |
| 2021 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses acapatamab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPCTerminatedPhase 1AmgenNCT03792841Written as acapatamab
- Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (mCRPC)TerminatedPhase 1/2AmgenNCT04631601Written as Acapatamab
- Study of AMG 160 in Subjects With Non-Small Cell Lung CancerTerminatedPhase 1AmgenNCT04822298Written as AMG 160
What changed recently
From the registry's own updates since Oct 18, 2026.
Results posted1
- Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPCNov 10, 2026NCT03792841
Codes
What other systems call acapatamab · ClinicalTrials.gg INT016714
- UNII (FDA) GW5EID3IDOACAPATAMABOne source FDA
- NCI Thesaurus C175736AcapatamabOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | GW5EID3IDO | ACAPATAMAB | One source FDA |
| NCI Thesaurus | C175736 | Acapatamab | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.